- Home
- FBRX vs CMTG Comparison
FBRX vs CMTG Comparison
Compare FBRX & CMTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$28.31
N/A
Current Price
$2.47
Company Overview
Basic Information| Metric | FBRX | CMTG |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 323.9M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FBRX | CMTG |
|---|---|---|
| Price | $28.31 | $2.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $67.00 | $3.00 |
| AVG Volume (30 Days) | 180.3K | ★ 697.8K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $36,000.00 | ★ $187,828,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.32 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.91 | $2.15 |
| 52 Week High | $35.62 | $4.30 |
Technical Indicators
Market Signals| Indicator | FBRX | CMTG |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 46.04 |
| Support Level | $26.67 | $2.19 |
| Resistance Level | $32.12 | $3.27 |
| Average True Range (ATR) | 2.39 | 0.21 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 30.31 | 40.24 |
Price Performance
Historical Comparison FBRX
CMTG
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About CMTG Claros Mortgage Trust Inc.
Claros Mortgage Trust Inc is a real estate investment trust. The company is focused mainly on creating a diversified portfolio of income-producing loans collateralized by institutional-quality commercial real estate.